Bristol Myers to Buy Heart Drug-Maker for $13 Billion
Pills arranged for a photograph in Tokyo, Japan. (Photographer: Kiyoshi Ota/Bloomberg)

Bristol Myers to Buy Heart Drug-Maker for $13 Billion

(Bloomberg) -- Drug giant Bristol Myers Squibb Co. will buy MyoKardia Inc. for $13.1 billion in cash in a deal to expand its offering of heart therapies.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.